Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EORTC CLTF 2018 | Update on CAR T-cell therapy at the City of Hope

Steven Rosen • 27 Sep 2018
EORTC CLTF 2018
Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Diffuse Large B-Cell Lymphoma General Lymphoma Mantle Cell Lymphoma Multiple Myeloma Non-Hodgkin Lymphoma CAR-T

We spoke with Steven Rosen, MD, of the City of Hope, Duarte, CA, about the latest CAR T-cell research at his centre, where a range of these agents are being investigated for the treatment of hematological malignancies, including for acute leukemias, multiple myeloma and lymphomas. This video was recorded at the European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 2018 Congress, held in St. Gallen, Switzerland.

More from Steven Rosen

2:03
The challenging field of hem-onc therapeutics
Steven Rosen • 21 Sep 2018
1:09
Non-hodgkin lymphoma advances in 2018
Steven Rosen • 21 Sep 2018
1:33
CAR T-cell therapy: on the way to success
Steven Rosen • 21 Sep 2018
2:09
Management & research for CTCL at the City of Hope
Steven Rosen • 27 Sep 2018

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
The content of VJHemOnc is intended for healthcare professionals